Domestic and foreign giants are betting on the prospect of biomedical "money"

Source: first financial daily, December 10, 2013, unlimited imagination, endless possibilities, countless competitions In the complex pharmaceutical manufacturing sequence, China's biopharmaceutical industry is accelerating to show different aspects of its risk surge and market temptation Recently, a group of data from global data released at bio China Bio Industry Conference showed that China's prescription drug market is expected to grow at a compound annual growth rate of 26% and reach US $315 billion in 2020, compared with us $48 billion in 2012, with a huge market improvement space Public information shows that the world vaccine market has exceeded 20 billion US dollars at present It is expected that in the next few years, the global vaccine market will grow at a rate of 14% per year, and the total global vaccine market will reach 35 billion US dollars by 2014 According to the report on investment analysis and Prospect Forecast of China's biopharmaceutical industry in 2011-2015 by CIC consultants, there are 36 vaccine manufacturers in China, which can produce 27 kinds of vaccines to prevent 27 diseases, with an annual production capacity of 1 billion doses; it is conservatively estimated that the scale of China's vaccine market at this stage is about 5 billion yuan, maintaining a compound annual growth rate higher than 20%, In 2012, the scale of China's vaccine market has exceeded 12 billion yuan Policy guidance: "the data we have at hand, in the third quarter of this year, the total profit of the pharmaceutical manufacturing industry is 22.57 billion yuan, an increase of 13% over the same period last year Compared with other industries, the profitability is very outstanding." Recently, Tan Sui, director of the Department of high and new technology and the second division of emerging industries of the national development and Reform Commission, said in public As the key to the development of strategic emerging industries, biomedical industry has attracted more and more attention from all aspects In 2012, the national "12th Five Year Plan" strategic emerging industries, biomedical industry has been listed as the key of strategic emerging industries On October 14th, the State Council issued several opinions on promoting the development of health service industry, which formally proposed that a health service industry system covering the whole life cycle, rich connotation and reasonable structure should be basically established by 2020 The total scale of health service industry will reach more than 8 trillion yuan, which will continue to increase the development possibility of biomedical industry "We have just approved 200 new biotechnologies to cope with the occurrence of more than 900 kinds of biological agents Among these drugs under development, there are 300 cancer treatment products and 170 treatment-related infectious diseases The annual output value of the biomedical industry has reached US $153 billion In the United States, 45 companies were listed on NASDAQ last year alone " Zhao Yajun, director of China Pharmaceutical International Exchange Center, told the bio conference According to the information from the emerging industry department of the high technology department of the national development and Reform Commission, in terms of investment development, the national development and Reform Commission and the Ministry of finance have launched and implemented the emerging industry plan At present, 141 venture capital funds have been set up, with a total scale of 39 billion yuan 28 venture capital funds have been approved and constructed in the field of biomedicine, with a total amount of 7.36 billion yuan raised and a number of innovative enterprises incubated At the same time, in terms of major projects and special projects, from 2011 to 2013, the Ministry of finance, the Ministry of industry and information technology and the health and Family Planning Commission jointly organized a special project for gene pool development to support the development of international development and supporting industries.